In this case, Xstrahl 100 was used to treat basal cell carcinoma on the forehead and temple of a patient.
Basal Cell Carcinoma Case Study
read more
Basal Cell Carcinoma
Xstrahl in Action: Multi-Disciplinary Management of Non-Melanoma Skin Cancer
In this video, Dr. Bernad, of Disney Family Cancer Center, discusses his experiences using the Xstrahl 100 device for treating skin cancer. https://vimeo.com/718400345 This was recorded at Hope Cancer Center and comes from the website of Providence Health &...
RADiant Treatment Case Study: Basal Cell Carcinoma
Check out this case study to see the great outcome of a basal cell carcinoma patient thanks to treatment with the RADiant system. See the full case study below.
USA Today: New technology helps treat skin cancer without surgery
The face of skin cancer is changing, as awareness is at an all-time high and medical technology is rapidly advancing. Still, the Skin Cancer Foundation reports that more than 5.4 million cases of nonmelanoma skin cancer are treated each year in the U.S., affecting 3.3...
Nestin+NG2+ Cells Form a Reserve Stem Cell Population in the Mouse Prostate
In the prostate, stem and progenitor cell regenerative capacities have been ascribed to both basal and luminal epithelial cells. Here, we show that a rare subset of mesenchymal cells in the prostate are epithelial-primed Nestin-expressing cells (EPNECs) that can...
Xstrahl Introduces One-Stop Shop Treatment System for Non-Melanoma Skin Cancer
April 24th, 2019 New 150kV superficial treatment system spotlighted on Xstrahl booth (No. 3420) at ESTRO show in Milan, Italy, April 26th-29th Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological...
Xstrahl in Action: Palliative radiotherapy for skin malignancies
According to the American Academy of Dermatology, it is estimated that non-melanoma skin cancer, including basal cell carcinoma and squamous cell carcinoma, affects more than 3 million Americans a year and 178,560 new cases of melanoma, including 91,270 invasive, will...
Xstrahl in Action: Orthovoltage X-rays for Postoperative Treatment of Resected Basal Cell Carcinoma in the Head and Neck
Surgery is the gold standard for treating basal cell carcinomas (BCCs), however in cases of positive tumor margins or recurrent disease, postoperative adjuvant or salvaging therapy is prefered to achieve good local control. In their paper “Orthovoltage X-rays for...
Stay safe this summer – use sunscreen!
Summer, has at last come and we are all looking forward to spending more time outdoors, lying on the beach, soaking in the sunshine, and getting a beautiful tan. Nothing can compare with these summer sunny pleasures! What about a proper protection from the other, ugly...
Contact Us